Walker Neal

CIK 00016044572 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001604457

Recent Transactions

50 trades

Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2026-06-09+3,318→ 3,318 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2026-06-09+70,000→ 70,000 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2026-02-03$3.47/sh−18,611→ 1,543,886 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2026-02-03−63,475→ 190,425 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2026-02-03+63,475→ 1,562,497 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2026-02-02+274,800→ 274,800 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2026-02-02+961,700→ 961,700 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2026-01-02−29,150→ 30,034 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2026-01-02$2.88/sh−9,952→ 1,499,022 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2026-01-02+29,150→ 1,508,974 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2025-06-10+62,728→ 62,728 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2025-06-10+2,413→ 2,413 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-05-01+9,467→ 1,482,799 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-05-01−9,467→ 0 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-05-01$1.38/sh−2,975→ 1,479,824 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-04-01$1.48/sh−3,042→ 1,473,332 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-04-01−9,467→ 9,467 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-04-01+9,467→ 1,476,374 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-03-01−9,466→ 18,934 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-03-01$1.99/sh−3,277→ 1,466,907 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-03-01+9,466→ 1,470,184 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-02-03+253,900→ 253,900 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2025-02-03+888,800→ 888,800 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-02-01$2.48/sh−3,559→ 1,460,718 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-02-01−9,467→ 28,400 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-02-01+9,467→ 1,464,277 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-01-02$2.48/sh−13,532→ 1,454,810 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-01-02+29,149→ 1,468,342 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-01-02+88,333→ 88,333 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-01-02−29,149→ 59,184 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-01-01$2.48/sh−3,904→ 1,439,193 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-01-01+9,467→ 1,443,097 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-01-01−9,467→ 37,867 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (right to buy)
2024-12-04−118,840→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-12-04$1.52/sh+118,840→ 1,501,973 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-12-04$3.76/sh−68,343→ 1,433,630 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-12-01+9,466→ 1,385,854 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-12-01−9,466→ 47,334 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-12-01$4.07/sh−2,721→ 1,383,133 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-11-01−9,467→ 56,800 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-11-01$2.09/sh−2,721→ 1,376,388 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-11-01+9,467→ 1,379,109 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-10-01$1.18/sh−2,722→ 1,369,642 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-10-01+9,467→ 1,372,364 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-10-01−9,467→ 66,267 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-09-01−9,466→ 75,734 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-09-01$1.18/sh−2,722→ 1,362,897 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-09-01+9,466→ 1,365,619 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (right to buy)
2024-08-09−43,548→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-08-09$0.72/sh+43,548→ 1,356,153 total

Companies

Recent Filings

Address

C/O ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE

LEXINGTON, MA, 02421

View on SEC.gov